We use cookies to improve your browsing experience on our website.
Please visit our Privacy Notice for more information about cookies and how we use them. We recommend that you accept the use of cookies for better navigation.

Innovation Has Been Integral to Us For More Than 50 Years

We have built upon our pioneering market leadership in negative pressure wound therapy and continue to revolutionize advanced wound care. Our comprehensive portfolio of advanced wound care solutions has changed the practice of medicine with proven clinical outcomes across new and growing categories, including dressings, disposables, and digital technology and connectivity.

Our research and development efforts are grounded in fundamental science and data in a wide variety of disciplines from immunology to biomechanics. Together, these have enabled us to make significant breakthroughs in advanced wound care. 

Our people make us different. All of us – scientists, engineers and technical teams – are dedicated to advancing the science of healing. We do much of this work at our Research and Development sites in the US (Texas) and in the UK (Dorset and Yorkshire).

Global Collaboration
We complement our own knowledge and expertise by working with academics and clinicians around the world. Such partnerships with the global medical community enable us to identify unmet clinical needs and to devise solutions that address these challenges. Then, we further test our solutions through extensive preclinical evaluations and user research, as necessary. This helps ensure our products are based on designs that perform well in the real world.

A Growing Portfolio
Our investment into research and development has yielded many leading brands as well as an extensive patent portfolio. We are committed to leveraging our size, scale and expertise to drive rapid development and commercialization of leading and new wound care technologies. We hold over 2,700 patents and continue to increase that number by about 100 every year. Our market-leading brands include:

V.A.C.® Therapy Systems - KCI pioneered negative pressure wound therapy (NPWT) and has been a leader in this category ever since.  V.A.C.® Therapy is the only NPWT device engineered with SENSAT.R.A.C. Technology, a proprietary technology that maintains and adjusts to deliver set pressure at the wound site. Additionally, EASYCLEAR PURGE™ Technology is designed to proactively aid in the prevention and clearance of blockages.

V.A.C.ULTA 4 Therapy System - provides four separate and distinct wound treatment options in the convenience of one therapy unit resulting in simplification of treatment for patients and caregivers. The four therapies include V.A.C.® Therapy System, ABTHERAOpen Abdomen Negative Pressure Therapy, PREVENA™ Incision Management System, and V.A.C. VERAFLO Therapy. V.A.C. VERAFLO Therapy combines the benefits of V.A.C.® Therapy with automated topical wound solution distribution and removal.  V.A.C. VERAFLO CLEANSE CHOICE Dressing is made for use with V.A.C. VERAFLO Therapy. - KCI pioneered negative pressure wound therapy (NPWT) and has been a leader in this category ever since.  V.A.C.® Therapy is the only NPWT device engineered with SENSAT.R.A.C. Technology, a proprietary technology that maintains and adjusts to deliver set pressure at the wound site. Additionally, EASYCLEAR PURGE™ Technology is designed to proactively aid in the prevention and clearance of blockages.

SENSAT.R.A.C. Technology - feedback sensing technology to ensure that selected negative pressure is accurately delivered at the wound site.

PREVENA Incision Management System - negative pressure wound therapy product designed specifically for the management of closed surgical incisions.

ABTHERA ADVANCE Open Abdomen Dressing - when used with a compatible V.A.C.® Therapy Unit, ABTHERA ADVANCE Open Abdomen Dressing forms a temporary abdominal closure system that helps surgeons take control early when managing a challenging open abdomen and helps achieve primary fascial closure.

PROMOGRAN Protease Modulating Matrix and PROMOGRAN PRISMA Wound Balancing Matrix – maintains a physiologically moist microenvironment at the wound surface. This environment is conducive to granulation tissue formation, epithelization and rapid wound healing.

Innovative Acelity Technologies
Our research and development efforts are grounded in fundamental science in a wide variety of disciplines from immunology to biomechanics. Together, these have enabled us to make significant breakthroughs in advanced wound care.